Yilun Wang1, Uyen-Sa D T Nguyen2, Nancy E Lane3, Na Lu4, Jie Wei5, Guanghua Lei6, Chao Zeng5, Yuqing Zhang7. 1. Xiangya Hospital, Central South University, Changsha, China. 2. University of North Texas Health Science Center, Fort Worth, and Boston University School of Medicine, Boston, Massachusetts. 3. University of California, Davis. 4. Arthritis Research Canada, Richmond, British Columbia, Canada. 5. The Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, and Xiangya Hospital, Central South University, Changsha, China. 6. Xiangya Hospital, Central South University, Hunan Key Laboratory of Joint Degeneration and Injury, and National Clinical Research Center of Geriatric Disorders (Xiangya), Changsha, China. 7. The Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston.
Abstract
OBJECTIVE: To assess the relation of symptomatic knee osteoarthritis (OA), knee pain, and radiographic knee OA to All-cause mortality and to identify mediators in the causal pathway. METHODS: Participants from the Osteoarthritis Initiative were divided into 4 groups: 1) symptomatic knee OA (i.e., both radiographic knee OA [Kellgren/Lawrence grade ≥2] and knee pain); 2) knee pain only; 3) radiographic knee OA only; and 4) neither radiographic knee OA nor knee pain. We examined the relation of knee OA status to All-cause mortality using a multivariable Cox proportional hazards model and assessed the extent to which the association was mediated by disability, physical component summary (PCS) and mental component summary (MCS) scores for quality of life (QoL), and use of oral pain-relief medications (i.e., nonsteroidal antiinflammatory drugs and opioids). RESULTS: Among 4,796 participants, 282 died over the 96-month follow-up period. Compared with those with neither radiographic knee OA nor knee pain, multivariable-adjusted hazard ratios (HRs) of mortality were 2.2 (95% confidence interval [95% CI] 1.6-3.1) for symptomatic knee OA, 0.9 (95% CI 0.6-1.4) for knee pain only, and 2.0 (95% CI 1.4-2.9) for radiographic knee OA only, respectively. Indirect effects (HRs) of symptomatic knee OA on mortality via disability and PCS of QoL were 1.1 (95% CI 1.0-1.4) and 1.2 (95% CI 1.0-1.4), respectively. No apparent mediation effect was observed through either MCS of QoL or oral pain-relief medications use. CONCLUSION: Participants with either symptomatic or radiographic knee OA were at an increased risk of All-cause mortality. Increased risk of mortality from symptomatic knee OA was partially mediated through its effect on disability and PCS of QoL.
OBJECTIVE: To assess the relation of symptomatic knee osteoarthritis (OA), knee pain, and radiographic knee OA to All-cause mortality and to identify mediators in the causal pathway. METHODS: Participants from the Osteoarthritis Initiative were divided into 4 groups: 1) symptomatic knee OA (i.e., both radiographic knee OA [Kellgren/Lawrence grade ≥2] and knee pain); 2) knee pain only; 3) radiographic knee OA only; and 4) neither radiographic knee OA nor knee pain. We examined the relation of knee OA status to All-cause mortality using a multivariable Cox proportional hazards model and assessed the extent to which the association was mediated by disability, physical component summary (PCS) and mental component summary (MCS) scores for quality of life (QoL), and use of oral pain-relief medications (i.e., nonsteroidal antiinflammatory drugs and opioids). RESULTS: Among 4,796 participants, 282 died over the 96-month follow-up period. Compared with those with neither radiographic knee OA nor knee pain, multivariable-adjusted hazard ratios (HRs) of mortality were 2.2 (95% confidence interval [95% CI] 1.6-3.1) for symptomatic knee OA, 0.9 (95% CI 0.6-1.4) for knee pain only, and 2.0 (95% CI 1.4-2.9) for radiographic knee OA only, respectively. Indirect effects (HRs) of symptomatic knee OA on mortality via disability and PCS of QoL were 1.1 (95% CI 1.0-1.4) and 1.2 (95% CI 1.0-1.4), respectively. No apparent mediation effect was observed through either MCS of QoL or oral pain-relief medications use. CONCLUSION: Participants with either symptomatic or radiographic knee OA were at an increased risk of All-cause mortality. Increased risk of mortality from symptomatic knee OA was partially mediated through its effect on disability and PCS of QoL.
Authors: Stephen J Kerr; Debra S Rowett; Geoffrey P Sayer; Susan D Whicker; Deborah C Saltman; Andrea Mant Journal: Br J Clin Pharmacol Date: 2010-05-06 Impact factor: 4.335
Authors: M Sattler; T Dannhauer; M Hudelmaier; W Wirth; A M Sänger; C K Kwoh; D J Hunter; F Eckstein Journal: Osteoarthritis Cartilage Date: 2012-03-03 Impact factor: 6.576
Authors: Jo S Price; Jasmine G Waters; Clare Darrah; Caroline Pennington; Dylan R Edwards; Simon T Donell; Ian M Clark Journal: Aging Cell Date: 2002-10 Impact factor: 9.304
Authors: F Eckstein; S Maschek; W Wirth; M Hudelmaier; W Hitzl; B Wyman; M Nevitt; M-P Hellio Le Graverand Journal: Ann Rheum Dis Date: 2008-06-02 Impact factor: 19.103
Authors: S Kluzek; M T Sanchez-Santos; K M Leyland; A Judge; T D Spector; D Hart; C Cooper; J Newton; N K Arden Journal: Ann Rheum Dis Date: 2015-11-05 Impact factor: 19.103
Authors: N Bhala; J Emberson; A Merhi; S Abramson; N Arber; J A Baron; C Bombardier; C Cannon; M E Farkouh; G A FitzGerald; P Goss; H Halls; E Hawk; C Hawkey; C Hennekens; M Hochberg; L E Holland; P M Kearney; L Laine; A Lanas; P Lance; A Laupacis; J Oates; C Patrono; T J Schnitzer; S Solomon; P Tugwell; K Wilson; J Wittes; C Baigent Journal: Lancet Date: 2013-05-30 Impact factor: 79.321
Authors: Justin Bucci; Xiaoyang Chen; Michael LaValley; Michael Nevitt; James Torner; Cora E Lewis; David T Felson Journal: Arthritis Rheumatol Date: 2021-12-30 Impact factor: 10.995
Authors: H Master; T Neogi; L F Callahan; A E Nelson; M LaValley; R J Cleveland; Y M Golightly; L M Thoma; Y Zhang; D Voinier; M B Christiansen; J T Jakiela; M Nevitt; C E Lewis; L A Frey-Law; D K White Journal: Osteoarthritis Cartilage Date: 2020-08-28 Impact factor: 6.576
Authors: Chao Zeng; Kim Bennell; Zidan Yang; Uyen-Sa D T Nguyen; Na Lu; Jie Wei; Guanghua Lei; Yuqing Zhang Journal: Ann Rheum Dis Date: 2020-09-16 Impact factor: 19.103